| Literature DB >> 29416554 |
Nicola de'Angelis1, Salomone Di Saverio2, Osvaldo Chiara3, Massimo Sartelli4, Aleix Martínez-Pérez5, Franca Patrizi6, Dieter G Weber7, Luca Ansaloni8, Walter Biffl9, Offir Ben-Ishay10, Miklosh Bala11, Francesco Brunetti1, Federica Gaiani12, Solafah Abdalla1, Aurelien Amiot13, Hany Bahouth10, Giorgio Bianchi1, Daniel Casanova14, Federico Coccolini8, Raul Coimbra15, Gian Luigi de'Angelis12, Belinda De Simone16, Gustavo P Fraga17, Pietro Genova18, Rao Ivatury19, Jeffry L Kashuk20, Andrew W Kirkpatrick21, Yann Le Baleur13, Fernando Machado22, Gustavo M Machain23, Ronald V Maier24, Alain Chichom-Mefire25, Riccardo Memeo26, Carlos Mesquita27, Juan Carlos Salamea Molina28, Massimiliano Mutignani29, Ramiro Manzano-Núñez30, Carlos Ordoñez30, Andrew B Peitzman31, Bruno M Pereira17, Edoardo Picetti32, Michele Pisano8, Juan Carlos Puyana33, Sandro Rizoli34, Mohammed Siddiqui1, Iradj Sobhani13, Richard P Ten Broek35, Luigi Zorcolo36, Maria Clotilde Carra37, Yoram Kluger10, Fausto Catena38.
Abstract
Iatrogenic colonoscopy perforation (ICP) is a severe complication that can occur during both diagnostic and therapeutic procedures. Although 45-60% of ICPs are diagnosed by the endoscopist while performing the colonoscopy, many ICPs are not immediately recognized but are instead suspected on the basis of clinical signs and symptoms that occur after the endoscopic procedure. There are three main therapeutic options for ICPs: endoscopic repair, conservative therapy, and surgery. The therapeutic approach must vary based on the setting of the diagnosis (intra- or post-colonoscopy), the type of ICP, the characteristics and general status of the patient, the operator's level of experience, and surgical device availability. Although ICPs have been the focus of numerous publications, no guidelines have been created to standardize the management of ICPs. The aim of this article is to present the World Society of Emergency Surgery (WSES) guidelines for the management of ICP, which are intended to be used as a tool to promote global standards of care in case of ICP. These guidelines are not meant to substitute providers' clinical judgment for individual patients, and they may need to be modified based on the medical team's level of experience and the availability of local resources.Entities:
Keywords: Antibiotic therapy; Colonoscopy; Emergency surgery; Gastrointestinal endoscopy; Iatrogenic colonoscopy perforation; Intra-abdominal infection; Laparoscopy; Open abdomen
Mesh:
Year: 2018 PMID: 29416554 PMCID: PMC5784542 DOI: 10.1186/s13017-018-0162-9
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Key questions used to develop the Consensus Conference on iatrogenic colonoscopy perforation (ICP)
| Risk of ICP | |
| Q1 | What are the general recommendations to minimize the risk of ICP during screening and therapeutic colonoscopies? |
| Q2 | What is the maximum incidence of ICP considered acceptable for centers where diagnostic or therapeutic colonoscopies are performed? |
| Diagnosis of ICP | |
| Q3 | What is the minimum information the endoscopist must report after diagnosing an ICP during a colonoscopy procedure? |
| Q4 | What are the minimum biochemical and imaging investigations that should be requested in the case of suspected ICP? |
| Conservative and endoscopic treatments of ICP | |
| Q5 | What are the indications for a conservative treatment or an immediate surgical intervention after an ICP diagnosis? |
| Q6 | What is the minimum duration of the hospital observation period for patients who have undergone successful endoscopic closure or conservative management of ICP? |
| Q7 | What investigations (clinical, biochemical, and imaging) should be performed during the observation period in patients who have undergone successful endoscopic closure or conservative management of ICP? |
| Q8 | What is the recommended type and duration of antibiotic therapy in patients who have undergone successful endoscopic closure or conservative management of ICP? |
| Q9 | What is the recommended type and duration of antithrombotic prophylaxis in patients who have undergone successful endoscopic closure or conservative management of ICP? |
| Q10 | How long is the fasting time in patients who have undergone successful endoscopic closure or conservative treatments for ICP? |
| Surgical treatment of ICP | |
| Q11 | Is explorative laparoscopy indicated in all patients with ICP? |
| Q12 | What are the indications for conversion from laparoscopy to open surgery in patients with surgical ICP? |
| Q13 | What are the key factors when choosing the best surgical approach for ICP? |
| Q14 | What are the indications for performing a diverting or terminal stoma in patients with ICP? |
| Q15 | What are the indications for drainages in patients with ICP? |
| Q16 | What are the indications for the use of damage control surgery in patients with ICP? |
| Follow-up of ICP | |
| Q17 | Is there any recommendation to perform a surveillance endoscopy after a successful ICP treatment? If so, what is the recommended timing for it? |
Grading of recommendations (from Guyatt et al.)
| Grade of recommendation | Description | Benefits vs. risks | Quality of supporting evidence | Implications |
|---|---|---|---|---|
| 1A | Strong recommendation, high-quality evidence | Benefits clearly outweigh risks and burdens, or vice versa | RCTs without important limitations or overwhelming evidence from observational studies | Strong recommendation, applies to most patients in most circumstances without reservation |
| 1B | Strong recommendation, moderate-quality evidence | Benefits clearly outweigh risk and burdens, or vice versa | RCTs with important limitations (inconsistent results, methodological flaws, indirect or imprecise) or exceptionally strong evidence from observational studies | Strong recommendation, applies to most patients in most circumstances without reservation |
| 1C | Strong recommendation, low-quality or very low-quality evidence | Benefits clearly outweigh risk and burdens, or vice versa | Observational studies or case series | Strong recommendation based on limited evidence; recommendations may change when higher quality or more extensive evidence becomes available |
| 2A | Weak recommendation, high-quality evidence | Benefits closely balanced with risks and burdens | RCTs without important limitations or overwhelming evidence from observational studies | Weak recommendation; best action may differ depending on circumstances, expertise of clinician, the patient in question, or other social issues |
| 2B | Weak recommendation, moderate-quality evidence | Benefits closely balanced with risks and burdens | RCTs with important limitations (inconsistent results, methodological flaws, indirect or imprecise) or exceptionally strong evidence from observational studies | Weak recommendation; best action may differ depending on circumstances, expertise of clinician, the patient in question, or other social issues |
| 2C | Weak recommendation, low-quality or very low quality evidence | Uncertainty in the estimates of benefits, risks, and burdens; benefits, risks, and burdens may be closely balanced | Observational studies or case series | Very weak recommendation; other alternatives may be equally reasonable |
Principal risk factors for iatrogenic colonoscopy perforations (ICP)
| Risk factors | References |
|---|---|
| Increasing age (> 65 years) | [ |
| Female gender | [ |
| Low BMI | [ |
| Low albumin level | [ |
| Presence of comorbidities | [ |
| Crohn’s disease and diverticulosis | [ |
| Admission in ICU | [ |
| Endoscopist’s experience | [ |
| Non-gastroenterologist endoscopists | [ |
| Low volume centers | [ |
| Previous abdominal surgery | [ |
| Colonic obstruction | [ |
| Bevacizumab therapy | [ |
| Therapeutic vs. diagnostic procedure | [ |
| Colonoscopy vs. sigmoidoscopy | [ |
| General anesthesia | [ |
Fig. 1Location and frequency of iatrogenic colonoscopy perforation
Main etiologies of iatrogenic colonoscopy perforation (ICP)
| Type of injury | |
| • Direct mechanical trauma | |
| • Barotrauma | |
| • Thermal/electrical injury | |
| Endoscopic therapeutic procedures at risk for ICP | |
| • Colorectal stenting | |
| • Polypectomy | |
| • Colonic dilation | |
| • Argon plasma coagulation (APC) | |
| • Endoscopic mucosal resection (EMR) | |
| • Endoscopic submucosal dissection (ESD) |
Risk factors to evaluate when considering damage control strategy for iatrogenic colonoscopy perforations (ICP)
| Risk factors | Description | References |
|---|---|---|
| Age | > 67 | [ |
| Delayed diagnosis | > 24 h | [ |
| Hemodynamic instability | Need for vasopressors before or during surgery | [ |
| “Blunt” ICP | Perforation caused by excessive dilatation or during diagnostic procedures | [ |
| Medication use | Chronic steroid therapy | [ |
| Severe sepsis | Peritonitis with organ failure | [ |
| High surgical risk | ASA III and IV | [ |
Fig. 2Comprehensive algorithm for the management of iatrogenic colonoscopy perforation